BRASILIA (Reuters) – Brazil’s health regulator Anvisa on Friday said it has given final approval for AstraZeneca Plc’s COVID-19 vaccine developed with Oxford University, which
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
